Leading companies have announced the launch of the American Alliance for Biomanufacturing (AAB). The new coalition aims to boost U.S. leadership in biomanufacturing innovation. Its goal is to strengthen the country’s industrial capabilities and resilience.
AAB unites key stakeholders from across the biomanufacturing sector. The alliance seeks to address critical challenges. These include supply chain security, technological advancement, and market development. The sector is increasingly vital for U.S. economic security, public health, and national defense.
The launch of AAB occurs at a strategic moment. The National Security Commission on Emerging Biotechnology (NSCEB) has called for a coordinated U.S. government approach. Its report urges action to maintain America’s global leadership in biomanufacturing. The NSCEB warns that inaction could lead to falling behind other nations.
Ajikumar Parayil, CEO of Manus, emphasizes the sector’s importance. He states, “Biomanufacturing is no longer just a scientific opportunity; it is a strategic imperative.” Parayil views the alliance as a step toward a national strategy. He notes that biomanufacturing can create jobs, bolster supply chains, and foster sustainable economic growth. Manus specializes in biobased production at scale in the U.S., supporting rural communities and advancing innovation.
Biomanufacturing utilizes biological systems to produce a wide range of products. These include energy sources, agricultural inputs, chemicals, textiles, and food ingredients. The industry is valued at $20 billion globally and is expected to grow rapidly in the coming years.
Brooke Coleman, Executive Director of AAB, highlights technological advances. These include new plastics, better fertilizers, and durable materials. He states, “By working together, the U.S. can maintain its competitive edge and lead in the development of biological products for the 21st-century economy.”
The alliance focuses on two core objectives. First, increasing demand for biobased products and technologies. Second, ensuring market readiness for both existing and new bioproducts. AAB also aims to strengthen domestic supply chains for biological materials and equipment. These efforts are designed to enhance U.S. competitiveness on the global stage.
Overall, the launch of the AAB marks a significant step toward national biomanufacturing growth. It reflects a broad industry effort to secure U.S. leadership in a rapidly evolving sector.
